Abstract
Introduction. Promotion of volunteerism plays an important role in the formation of civil society in Russia. The animal welfare movement is one of the areas of such socially significant activities. Studies in this field are of relevance and practical significance, since the development of the animal welfare movement is a kind of social marker of the moral state of society. The study is aimed at identifying the organizational forms of the animal welfare movement in Russia as well as the motivation for people to participate in this activity, and at drawing up a sociological portrait of the Russian animal welfare activist. Materials and Methods. The article presents the results of two sociological studies: a survey of animal welfare activists (2017) done using the method of informal guided (semi-structured) interviews and an online survey of members of animal welfare groups on social networks (2019) conducted using ‘snowball sampling’ technique. Results. A portrait of a typical representative of the animal welfare movement in Russia has been done. The main achievements and problems of the animal welfare movement in Russia have been identified. The social composition of the animal welfare movement has been revealed as well as the activists’ motivation for participation in volunteering. An assessment of the level of development of the animal welfare in Russia as a whole and in the home regions of the animal welfare activists has been presented. Discussion and Conclusion. The animal welfare movement is represented at the regional and federal levels, the degree of its development being a certain marker of the state of public morality and the level of maturity of civil society. However, the effectiveness of animal welfare activities is constrained by a number of factors: legal, organizational, financial, and informational ones. Overcoming these barriers depends on a sustainable dialogue between the authorities and civil society, especially at the regional level. The practical significance of the study lies in the possibility of using its results by the authorities and volunteer movements for the implementation of civil initiatives and their legislative support at the federal and regional levels.
Highlights
In the context of global competition between intellectual industries and building transnational structures that ensure socio-economic development, joining the world’s top 5 most innovative economies is possible only in case of increasing the science intensity of the business sector of the economy
Based on the results of the study conducted, the article gives an analysis of the industry average values of the costs of enterprises for research and development (R&D) in economically developed countries and outlines proposals for achieving a similar level of costs for such work in Russia
The practice of strategizing Russia’s regions makes it possible to single out the regional dimension as a self-sufficient subject of cognitive modeling
Summary
Ensuring the safety of medicines is the basis for the existence and functioning of any pharmacovigilance system as a type of activity aimed at obtaining and processing information about the undesirable consequences of the use of medicines. Исследование особенностей функционирования систем фармаконадзора в странах – участницах международной программы мониторинга безопасности лекарственных средств позволило выделить несколько типов организации сбора информации о нежелательных реакциях лекарственных средств: централизованный, децентрализованный и смешанный. Такой тип организации системы фармаконадзора представлен, например, в США, где все контролирующие функции в сфере оборота лекарственных средств возложены на Управление по санитарному надзору за качеством пищевых продуктов и медикаментов (Food and Drug Administration, FDA), которое является одним из федеральных исполнительных департаментов Министерства здравоохранения и социальных служб США. Основой функционирования централизованной системы фармаконадзора в США является программа MedWatch, позволяющая специалистам здравоохранения, пациентам и потребителям предоставлять в FDA информацию о нежелательных реакциях, возникающих при применении рецептурных и безрецептурных лекарственных средств, особенностях применения биологических препаратов, специальных пищевых продуктов (например, детских питательных смесей), а также о медицинских приборах и косметологических средствах. The centralized type of organization of the pharmacovigilance system exemplified by the U.S Food and Drug Administration (FDA)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
